Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
From 1995 to 2016, hepatocellular carcinoma incidence in rural populations climbed by 218%.
Cirrhosis severity and CD4 cell counts were linked to a greater chance of developing liver cancer.
Diagnosed while a student, Ella Neal found hope for fibrolamellar HCC, a rare liver disease, at the University of Colorado Cancer Center.
An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.
In a small study, 80% of participants treated with Cabometyx and Opdivo underwent successful surgery.
People treated with direct-acting antivirals had better overall survival than those whose hepatitis C remained untreated.
Barriers still stand in the way of making treatment available to all who need it.
But a simple improvement in dietary intake reversed fatty liver disease and staved off cancer.
Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
The early cancer is detected, the easier it is to treat.
People with NAFLD have an elevated risk of cancer, largely due to high liver cancer incidence.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.